Senda Biosciences
Biotechnology, 20 Acorn Park Dr, Cambridge, Massachusetts, 02140, United States, 51-200 Employees
Who is SENDA BIOSCIENCES
Senda Biosciences, Inc. is uniquely positioned to transform human health by harnessing millions of years of evolution to program targeted, potent and tunable medicines. Nature has provide...
Read More
-
Headquarters: 20 Acorn Park Dr, Cambridge, Massachusetts, 02140, United States
-
Date Founded: 2017
-
Employees: 51-200
-
Revenue: $25 Million to $50 Million
-
Active Tech Stack: See technologies
Industry: Biotechnology
SIC Code: 8731
Does something look wrong? Fix it. | View contact records from SENDA BIOSCIENCES
Senda Biosciences Org Chart and Mapping
Email
Phone
Sign in to CIENCE GO Data to uncover contact details
Free credits every month
Frequently Asked Questions Regarding Senda Biosciences
Answer: Senda Biosciences's headquarters are located at 20 Acorn Park Dr, Cambridge, Massachusetts, 02140, United States
Answer: Senda Biosciences's official website is https://sendabiosciences.com
Answer: Senda Biosciences's revenue is $25 Million to $50 Million
Answer: Senda Biosciences's SIC: 8731
Answer: Senda Biosciences has 51-200 employees
Answer: Senda Biosciences is in Biotechnology
Answer: Senda Biosciences contact info: Phone number: Website: https://sendabiosciences.com
Answer: Senda Biosciences, Inc. is uniquely positioned to transform human health by harnessing millions of years of evolution to program targeted, potent and tunable medicines. Nature has provided the codes to program human cells both within the cell (mRNA), and, remarkably, to the cell - using what surrounds it. The trillions of non-human cells in the human ecosystem have evolved natural nanoparticles that precisely shuttle biomolecules into human cells, providing the missing pieces to fully unlock programmable medicines. Sendas proprietary platform includes the first-ever atlas of nature-derived programmable systems at the molecular level and across all kingdoms of life accessing the entire code provided by nature required to program cells. With this platform, Senda is developing a new class of SendRNATM medicines. The unique properties of these medicines create new frontiers for mRNA therapeutics and vaccines for infectious, genetic, autoimmune, and metabolic diseases and oncology indications with further potential to transform the gene editing and protein-based therapy landscapes as well. Based in Cambridge, MA, Senda was founded by Flagship Pioneering.
Premium Sales Data for Prospecting
-
Sales data across over 200M records
-
Up-to-date records (less decayed data)
-
Accurate Email Lists (real-world tested)
-
Powerful search engine and intuitive interface
Get Full Access
Sign in to CIENCE GO Data to uncover contact details
Free credits every month